Veronica Tayson

Veronica Tayson, RPh, currently serves as the Head of EU Regulatory Affairs at Perspective Therapeutics since September 2025. Prior to this role, Veronica held various positions in regulatory affairs, including Director of Quality and Regulatory Affairs at Curium Pharma, focusing on radiopharmaceuticals, and Associate Director of Regulatory Affairs at KalVista Pharmaceuticals, specializing in rare diseases. Veronica's experience also includes significant contributions as a Regulatory Affairs Project Manager at Abbott, overseeing global regulatory affairs development and strategy, and serving as Senior Regulatory Affairs professional at Bristol Myers Squibb, where responsibilities encompassed immuno-oncology and immunology regulatory activities for the UK and Ireland. Additional roles include Global Senior Regulatory Affairs Specialist at Worldwide Clinical Trials and Regulatory Affairs Pharmacist/Executive at APLC. Veronica began a career in the healthcare sector as a Medical Technical Officer at North Middlesex University Hospital NHS Trust. Veronica holds a BSc in Pharmacy.